Latest Nebulizer Stories
Mexico City-based distributor of Omron products becomes a wholly-owned subsidiary of Omron Healthcare, Inc. BANNOCKBURN, Ill., Feb. 5 /PRNewswire/ -- Omron Healthcare, Inc.
JEFFERSON, N.C., Dec. 15 /PRNewswire/ -- Inhalers used for delivering albuterol, a fast-acting bronchial dilator, currently use propellants such as ozone-depleting CFC's, which are banned by the FDA beginning December 31st, 2009, or replacement HFA's.
BANNOCKBURN, Ill., Dec. 4 /PRNewswire/ -- Omron Healthcare, Inc.
MIDLOTHIAN, Virginia, Nov. 12 /PRNewswire/ -- On Saturday, November 15, PARI Respiratory Equipment will be featured on the ABC Family show Today's Family, as part of their "Breathe Easier" series.
MONTEREY, Calif., Nov.
MIDLOTHIAN, Va., Oct. 28 /PRNewswire/ -- Today, PARI Respiratory Equipment presented a comparative study of three commercially available, breath-enhanced nebulizers and their in-vitro performance and delivery efficiency of budesonide inhalation suspension (Pulmicort Respules, AstraZeneca).
MIDLOTHIAN, Va., Oct.
Kamada, a biopharmaceutical company, has reported positive data from its Phase II study evaluating inhaled Alpha-1 Antitrypsin delivered via an investigational eFlow Nebulizer System, in the treatment of cystic fibrosis.
Kamada (TASE:KMDA), a biopharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today positive data from its Phase II study evaluating inhaled Alpha-1 Antitrypsin (AAT) delivered via an Investigational eFlow(R) Nebulizer System (PARI Pharma GmbH), in the treatment of cystic fibrosis.
Transave, a biopharmaceutical company, has secured a $12.5 million venture loan from CIT Healthcare and Compass Horizon Funding Company, an affiliate of Horizon Technology Finance Management.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.